|
|
Anemia CME Posttest |
Anemia Management: The Changing Spectrum of Care
Medical Education Resources
CME Internet Course
Introduction
Posttest
Name
Degree
Specialty
Institution/Affiliation
Address
City
State Zip
Phone
Fax E-MailThis program has been certified for physicians and nurses. It is free of charge. To earn CME credit, please circle the correct responses to the Posttest questions and return with the completed Evaluation Form to Medical Education Resources, Inc. via fax at (303) 798-5731 or mail at 1500 West Canal Court, Suite 500, Littleton, Colorado 80120-5617.
1. Target hematocrit levels for epoetin therapy recommended by DOQI workgroup are:
a.) 30% to 33%
b.) 33% to 36%
c.) 36% to 39%
2. It is suggested that physicians test serum ferritin and TSAT levels in patients with anemia at least:
a.) every 3 months
b.) every 6 months
c.) every 12 months
3. The route of administration for EPO that is most effective for most patients is:
a.) oral
b.) sq
c.) IV
4. Anaphylaxis is most common with
a.) ferrous sulfate PO
b.) ferrous gluconate IV
c.) iron dextran IV
5. In patients with anemia of chronic renal insufficiency, the target hemoglobin is
a.) 9 to 10 g/dl
b.) 10 to 11 g/dl
c.) 11 to 12 g/dl
6. According to the HCFA study, ___% of pre-ESRD patients in the US received EPO.
a.) <25%
b.) 25% to 50%
c.) 50% to 75%
d.) >75%
7. Which of the following is a cardiac benefit of partial correction of anemia?
a.) regression of left ventricular hypertrophy
b.) increased EKG evidence of ischemia on treadmill testing
c.) maintain high output
d.) maintain low peripheral resistance
8. What is the correct dosing of sodium ferric gluconate complex in sucrose for iron repletion?
a.) 62.5mg x 8 consecutive treatments
b.) 125mg x 8 consecutive treatments
c.) 150mg x 8 consecutive treatments
9. Maintaining a target Hct/Hgb can:
a.) improve survival
b.) cause regression of LVH
c.) improve cognitive function
d.) all of the above
10. The reason for decreased risk of anaphylaxis with ferric gluconate is believed to be due to:
a.) lower iron content
b.) stability of gluconate
c.) absence of dextran chains
Sponsored by Medical Education Resources, Inc.
Supported by an unrestricted educational grant from Schein Pharmaceutical, Inc.